Related Experiment Video

Updated: Jul 5, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K

BCL2 inhibition stimulates dendritic cell function for improved anticancer immunotherapy

Peng Liu1,2, Liwei Zhao1,2, Guido Kroemer3,4,5

  • 1Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.

Genes and Immunity
|January 24, 2024
PubMed

Insights

Researchers identified BCL2 as a dendritic cell (DC) immune checkpoint. Inhibiting BCL2 enhances anti-cancer immunity, offering a new dual checkpoint blockade strategy for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Genetics

Background:

  • Dendritic cells (DCs) are crucial for initiating anti-cancer immunity.
  • Identifying DC-specific immune checkpoints can enhance immunotherapy.
  • CRISPR/Cas9 screening offers a powerful tool for functional genomics.

Purpose of the Study:

  • To identify novel DC-specific immune checkpoints.
  • To evaluate the therapeutic potential of targeting these checkpoints in cancer.

Main Methods:

  • Developed a CRISPR/Cas9-based screening platform for DC genotype-phenotype analysis.
  • Performed whole-genome screening to identify gain-of-function phenotypes.
  • Investigated the role of BCL2 in DC function and anti-cancer immunity.
  • Assessed the efficacy of BCL2 inhibition alone and in combination with PD-1 blockade in mouse models.

Main Results:

  • Identified BCL2 as a DC-specific immune checkpoint.
  • BCL2 inhibition enhanced antigen presentation by conventional type-1 dendritic cells (cDC1).
  • Targeting BCL2 mediated T cell-dependent anti-cancer immunity.
  • Combined BCL2 inhibition (venetoclax) and PD-1 blockade synergistically increased anti-cancer efficacy in mice.

Conclusions:

  • BCL2 represents a novel DC-specific immune checkpoint.
  • Dual blockade of BCL2 and PD-1 offers a promising strategy for enhancing cancer immunotherapy.
  • Improving DC function and preventing T cell exhaustion can be combined for greater therapeutic benefit.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
735
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367